Drugmaker KVK Tech pulls batch of beta blockers after finding opioid tablet on packaging line
05 Oct 2023
Preview
Source: FiercePharma
For patients, an opioid tablet would be tough to distinguish from the intended betaxolol prescription.
The Oxycontin pill was found during a line clearance procedure after the beta blockers were already packed up. So far, the generics maker hasn’t heard reports of a foreign tablet appearing in its medicine, according to an FDA statement on the recall.
Beta blockers are prescribed for heart problems such as rhythm disorders, angina and hypertension. The meds slow down a patient’s heart rate, making for a dangerous situation if a patient were to accidentally consume an opioid in addition to their beta blockers.
The two tablets look almost identical, featuring only minor differences that a patient likely wouldn’t catch, the FDA said.
The affected batch has an expiration date of June 2027. The company has notified its distributors and customers and believes that a “small number” of bottles may have been sent out to retail pharmacies.
The same letter detailed issues with the plant’s investigation of foreign particles found in a lot of an ADHD drug.
Later that year, KVK received another letter for skirting cleaning protocols, among other shortfalls.
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
Targets
-Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.